Skip to content

Based on the changes of intestinal microecology, the biological basis of damp-heat syndrome and the mechanism of related prescriptions were discussed

Based on the changes of intestinal microecology, the biological basis of damp-heat syndrome and the mechanism of related prescriptions were discussed

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020914
Enrollment
Unknown
Registered
2019-01-22
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TCM warm-disease-dampness-heat syndrome

Interventions

Group 1:modified huopo xialing decoction

Sponsors

College of Traditional Chinese Medicine, Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. aged 14 to 65 years old; 2. In line with the diagnostic criteria of TCM syndrome of warm and humid heat; 3. Meet the diagnostic criteria of upper respiratory tract virus infection; 4. The onset of illness within 48 hours; 5. The subject is informed and signs the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. Accompanied by the following diseases or conditions: chronic respiratory diseases, diseases of the cardiovascular system (except for high blood pressure), kidney disease, liver disease, blood system diseases, neurological and neuromuscular disease, metabolic and endocrine system disease, immune function, inhibit (including the application of immunosuppressant or HIV infection to low immune function etc.); 2. exclude the common cold, acute pharyngitis, tonsillitis, rhinitis and sinusitis and other types of upper respiratory tract infection, pneumonia, bronchitis and other lower respiratory tract infection; 3. Exclude severe and critical cases of influenza, or accompanied by serious complications of influenza, such as pneumonia, nervous system injury, heart damage, myositis, rhabdomyolysis syndrome and septic shock; 4. 0besity, pregnancy, breastfeeding women.

Design outcomes

Primary

MeasureTime frame
disease duration;severity of disease;complication rates;Pharmacoeconomic indicators;The percentage of antimicrobial application;Incidence of hospitalization;The time it takes to recover to the pre-onset condition;

Countries

China

Contacts

Public ContactChen Xiaoyin

College of Traditional Chinese Medicine, Jinan University

tchenxiaoyin@jnu.edu.cn+86 13822263950

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026